Alembic Pharma Jumps On U.S. FDA Nod For Fesoterodine Fumarate Tablets

Shares of Alembic Pharmaceuticals Ltd. rose 1.5% to Rs 773.5 apiece after the company received the U.S. FDA nod for its ANDA for Fesoterodine Fumarate Extended-Release tablets, 4 mg and 8 mg. It is indicated for treatment of overactive bladder in adults. The estimated market size of $225 million for twelve months ending September 2021, according to IQVIA.

Read More →

Nifty Head towards 18,200 in Coming Months [02-02-2022]

We believe the risk-reward has turned favourable for long term investment as majorpart of the price wise correction (8%) is already over. Therefore, investors should use the current volatility in the markets to accumulate qualitystocks as we expect the Nifty to surpass the immediate hurdle of 17600 and eventually headtowards 18200 in coming months.

Read More →